• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

仓鼠腺病毒诱导的可移植肉瘤的化学疗法和免疫疗法

Chemo- and immunotherapy of an adenovirus-induced transplantable sarcoma in hamsters.

作者信息

Todorov D K, Silyanovska K K, Maneva K M, Ilarionova M V, Gantchev G T, Getov C M

出版信息

Neoplasma. 1987;34(3):287-94.

PMID:3039387
Abstract

The subcutaneous transplantable adenovirus sarcoma (TAVS) in hamsters was created in 1972 at the Oncological Research Institute and maintained by serial subcutaneous transplantation. It showed the highest sensitivity against some alkylating drugs and antimetabolites--cyclophosphamide, sarcolysine, methotrexate and 6-mercaptopurine. In some degree, TAVS is able to differentiate antitumor drugs of one group by the intensity of their antitumor activity. Among the drugs, cyclophosphamide was the most active and 6-mercaptopurine and 5-fluorouracil the least active. Antitumor drugs of plant origin, antibiotics and methyl-CCNU had a weak activity on subcutaneous TAVS. Intramuscular TAVS showed a similar sensitivity, with some differences for olivomycin, bruneomycin and vinblastine. Intracerebral TAVS was sensitive against antitumor agents penetrating through the hemato-encephalic barrier and which were active against its subcutaneous and intramuscular form. BCG vaccine and levamisole applied separately did not show any activity on the growth of TAVS. Combined immunochemotherapy with cyclophosphamide plus BCG gave a better enhancement of the antitumor effect of the cytostatic than that of the combination of methotrexate plus BCG and cyclophosphamide plus levamisole. These results showed that TAVS in hamsters may be used as a suitable experimental model for pharmacological studies of antitumor agents and combined immunochemotherapy.

摘要

仓鼠皮下可移植腺病毒肉瘤(TAVS)于1972年在肿瘤研究所培育而成,并通过连续皮下移植进行维持。它对某些烷化剂和抗代谢物——环磷酰胺、溶肉瘤素、甲氨蝶呤和6-巯基嘌呤表现出最高的敏感性。在某种程度上,TAVS能够根据抗肿瘤药物的抗肿瘤活性强度区分同一组中的不同药物。在这些药物中,环磷酰胺活性最强,6-巯基嘌呤和5-氟尿嘧啶活性最弱。植物来源的抗肿瘤药物、抗生素和甲基环己亚硝脲对皮下TAVS的活性较弱。肌肉内TAVS表现出类似的敏感性,对橄榄霉素、棕褐霉素和长春碱有一些差异。脑内TAVS对能够穿透血脑屏障且对其皮下和肌肉内形式有活性的抗肿瘤药物敏感。单独应用卡介苗(BCG)疫苗和左旋咪唑对TAVS的生长没有任何作用。环磷酰胺联合卡介苗的免疫化学疗法比甲氨蝶呤联合卡介苗以及环磷酰胺联合左旋咪唑的组合更能增强细胞抑制剂的抗肿瘤效果。这些结果表明,仓鼠中的TAVS可作为抗肿瘤药物药理研究和联合免疫化学疗法的合适实验模型。

相似文献

1
Chemo- and immunotherapy of an adenovirus-induced transplantable sarcoma in hamsters.仓鼠腺病毒诱导的可移植肉瘤的化学疗法和免疫疗法
Neoplasma. 1987;34(3):287-94.
2
Influence of antitumor drugs of natural origin on the intramuscular and subcutaneous form of five transplantable tumor models.
Biomedicine. 1981 Mar;35(1):25-7.
3
Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.卡介苗甲醇提取残渣(mer)组分对小鼠实体瘤的免疫治疗研究
Natl Cancer Inst Monogr. 1973 Dec;39:33-55.
4
Single-agent therapy for Hodgkin's disease.霍奇金淋巴瘤的单药治疗。
Arch Intern Med. 1973 Mar;131(3):377-87.
5
[A method of primary selection of antitumor agents].
Vopr Onkol. 1971;17(2):62-6.
6
[Experimental basis for methods of determining individual sensitivity of tumors to alkylating antitumor preparations].[确定肿瘤对烷化剂抗肿瘤制剂个体敏感性方法的实验依据]
Biull Eksp Biol Med. 1969 Dec;68(12):68-70.
7
Chemotherapy of breast cancer.乳腺癌的化疗
Clin Obstet Gynecol. 1968 Jun;11(2):401-15.
8
[Antineoplastic chemotherapy in dermatology. Clinical experimental and anatomico pathologic study on the activities of some antimitotics. Findings in the general and local therapy].[皮肤科的抗肿瘤化疗。某些抗有丝分裂药物活性的临床实验及解剖病理学研究。全身及局部治疗的结果]
Omnia Med Ther. 1970 Jul-Sep;48(3):209-348.
9
Sensitivity of Nakahara-Fukuoka sarcoma to antitumor agents, especially to purine analogs.
Gan. 1969 Feb;60(1):115-7.
10
Enhancement of antitumor response to sarcoma 45 in rats by combination of whole-body hyperthermia and interleukin-2.全身热疗与白细胞介素-2联合增强大鼠对肉瘤45的抗肿瘤反应。
Eksp Onkol. 2004 Mar;26(1):67-70.